Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody(TM) ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Stock Information for Greenpro Capital Corp.

Loading

Please wait while we load your information from QuoteMedia.